GlassScriptPhysician profile
Joshua Waddell
NPI 1053862862
$2,001.11
in general payments reported to CMS, 2019-2025
14 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $187 · 2023: $186 · 2024: $260 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $960 · Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $960.00 |
| Food and Beverage | $647.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,062.88 | 2025 | Cobenfy |
| Abbvie INC. | $318.71 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $206.01 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $71.08 | 2021-2025 | Rexulti |
| Indivior INC. | $64.24 | 2022-2024 | Sublocade |
| Neurocrine Biosciences, INC. | $51.38 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $51.38 | 2023-2024 | Uzedy, Austedo |
| Corium, LLC | $44.57 | 2023 | Azstarys |
| Vanda Pharmaceuticals INC. | $37.39 | 2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $26.42 | 2024 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $19.17 | 2024 | Trintellix |
| Axsome Therapeutics, INC. | $18.58 | 2024 | Auvelity |
| Supernus Pharmaceuticals, INC. | $15.47 | 2023 | Qelbree |
| Tris Pharma INC | $13.83 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Waddell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.